Literature DB >> 8609514

Neurosurgery in a patient with Creutzfeldt-Jakob disease after pituitary derived growth hormone therapy in childhood.

S J Holmes1, J W Ironside, S M Shalet.   

Abstract

The case of a young man who had previously received pituitary derived growth hormone for treatment of radiation induced growth hormone deficiency is reported. He underwent neurosurgery for presumed recurrence of a posterior fossa tumour but was subsequently shown to have Creutzfeldt-Jakob disease, confirmed on necropsy. The risk of transmission of Creutzfeldt-Jakob disease by neurosurgical instruments is discussed. Since the occurrence of this case the Department of Health have issued guidelines concerning neurosurgery and ophthalmic surgery in patients who have previously received treatment with pituitary derived growth hormone and may therefore be at risk of developing Creutzfeldt-Jakob disease. Surgical instruments used on such patients should under no circumstances be reused, and should be destroyed after use.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609514      PMCID: PMC1073860          DOI: 10.1136/jnnp.60.3.333

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  6 in total

Review 1.  "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease.

Authors:  P Brown; M A Preece; R G Will
Journal:  Lancet       Date:  1992-07-04       Impact factor: 79.321

2.  Creutzfeldt-Jakob disease in recipients of human growth hormone in the United Kingdom: a clinical and radiographic study.

Authors:  H S Markus; L W Duchen; E M Parkin; A B Kurtz; H S Jacobs; D C Costa; M J Harrison
Journal:  Q J Med       Date:  1992-01

Review 3.  Creutzfeldt-Jakob disease in a physician: a review of the disorder in health care workers.

Authors:  J R Berger; N J David
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

4.  Transmission of Creutzfeldt-Jakob disease by handling of dura mater.

Authors:  T Weber; H Tumani; B Holdorff; J Collinge; M Palmer; H A Kretzschmar; K Felgenhauer
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321

5.  Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine.

Authors:  P Brown; L Cervenáková; L G Goldfarb; W R McCombie; R Rubenstein; R G Will; M Pocchiari; J F Martinez-Lage; C Scalici; C Masullo
Journal:  Neurology       Date:  1994-02       Impact factor: 9.910

6.  PL(92)CO/4-neuro and ophthalmic surgery procedures on patients with or suspected to have, or at risk of developing, Creutzfeldt-Jakob disease (CJD), or Gerstmann-Straussler-Scheinker syndrome (GSS)

Authors:  A Wight
Journal:  J Public Health Med       Date:  1993-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.